logo

For the Inventor, By the Inventor

Quakertown, PA, United States of America

Donald William Ludovici

This inventor holds 36 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in HIV Inhibition. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica, Ortho-Mcneil Pharmaceutical Corp.. Active years: 2000-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald William Ludovici. Retrieved from https://idiyas.com/inventor/donald-william-ludovici

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 

% Patents Active = 55.6



Average Co-Inventor Count = 9.0

ph-index = 11

Forward Citations = 396(Granted Patents)


Location History:

  • Quarkertown, PA (US) (2005)
  • Titusville, NJ (US) (2007)
  • Spring House, PA (US) (2002 - 2014)
  • Quakertown, PA (US) (2000 - 2018)

Company Filing History:

goldMedal28 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal4 out of 32 
 
Janssen Pharmaceutica
 patents
bronzeMedal1 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
4. 3 out of 834,513 
Other
 patents

Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Inhibition
CB-1 Agonists
TRPM8 Modulators
Cancer Treatment
Pyrimidine Derivatives
Triazine Derivatives
Benzimidazole Derivatives
Imidazolin-5-One
Prodrugs
Cell Proliferative Disorders
Glycogen Synthase Kinase 3
Neuropeptide Y Receptor
36 patents (USPTO):Explore Patents
1. 10118900 - Benzimidazole derivatives useful as CB-1 inverse agonists (2018-11-06),
2. 10077261 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer (2018-09-18),
3. 9732061 - Cinnoline derivatives useful as CB-1 receptor inverse agonists (2017-08-15),
4. 9434711 - Sulfonamides as TRPM8 modulators (2016-09-06),
5. 9096521 - Cold menthol receptor antagonists (2015-08-04),
6. 8809327 - Sulfonamides as TRPM8 modulators (2014-08-19),
7. 8653099 - Cold menthol receptor antagonists (2014-02-18),
8. 8530655 - HIV replication inhibiting pyrimidines (2013-09-10),
9. 8324217 - Cold menthol receptor antagonists (2012-12-04),
10. 8153682 - Sulfonamides as TRPM8 modulators (2012-04-10),
11. 8143259 - Cold menthol receptor antagonists (2012-03-27),
12. 8026248 - HIV inhibiting pyrimidine derivatives (2011-09-27),
13. 8003789 - HIV replication inhibiting pyrimidines (2011-08-23),
14. 7795440 - N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders (2010-09-14),
15. 7763631 - Prodrugs of HIV replication inhibiting pyrimidines (2010-07-27),

Title: The Innovative Journey of Donald William Ludovici

Introduction: Donald William Ludovici, a talented inventor hailing from Quakertown, PA (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Ludovici's latest patents showcase his prowess in the field of technology, with inventions ranging from cutting-edge software solutions to innovative hardware designs that have revolutionized various industries.

Career Highlights: Throughout his illustrious career, Ludovici has consistently pushed the boundaries of innovation, earning a reputation as a visionary inventor. His ability to identify gaps in the market and develop unique solutions has set him apart in the competitive world of technology.

Collaborations: Ludovici has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that have had a lasting impact on the industry.

Conclusion: Donald William Ludovici's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…